Greetings from Turku! This week, we had the pleasure of participating in the fourth Nordic Metabolomics Conference, where our Senior Data Scientist, Sini Kerminen, had an insightful presentation about Population-scale metabolomics from blood and urine. We also had an

New in ageing research: the role of metabolomic age in chronic disease risk A recent study by Shang et al. published in Aging Cell explored how metabolomic age associates with the risk of a wide range of chronic diseases including cardiovascular disease, chronic obstructive

Are you coming to EASD Annual Meeting 2024 on September 9-13? We'll have a talk by our Data Scientist Kirsten Schut. You can also meet Nightingale team at our booth C11. Learn more: research.nightingalehealth.com/meet-us-at-eas…

Are you coming to World Congress of Epidemiology 2024 in Cape Town on September 24-27? We'll have a talk by our Data Scientist Kirsten Schut. You can also meet Nightingale team at our booth 10. See you at the event!

Welcome to our webinar “Metabolomic signatures of rare disease-associated variants” on 2 October at 3 p.m. CEST! In this webinar, our Chief Scientific Officer Jeffrey Barrett will show how metabolomics data from 500,000 people in the UK Biobank can help understand rare genetic variants

Our webinar “Metabolomic signatures of rare disease-associated variants” by Jeffrey Barrett is tomorrow! Remember to sign up and join us on 2 October at 3 p.m. CEST. Learn more about the webinar and sign up: lyyti.fi/reg/webinar-oc…

Cardiovascular research highlight: Metabolomics improves risk stratification for incident heart failure A study published in European Journal of Heart Failure explored the predictive value of metabolomics for incident heart failure using 68,311 individuals from the UK Biobank

Last week, we had the pleasure of attending a seminar on metabolomics and microsampling, hosted by SciLifeLab and Nordic Metabolomics Society at Karolinska Institutet in Stockholm. Our Founder @PeterWyrtz introduced Nightingale Health's end-to-end remote blood collection solution, RemoteOmics.

Maternal health research highlight: Recent study links pre-pregnancy obesity to increased inflammation and depression risk Recent research from the pre-birth cohort Barwon Infant Study reveals that pre-pregnancy obesity is not only a risk factor for depression during pregnancy

Are you coming to ASHG Annual Meeting 2024 next week on November 5-9? We'll have a talk by our Chief Scientific Officer Jeffrey Barrett and a poster by our Principal Scientist Luke Jostins-Dean. You can also meet Nightingale team at our booth 322. Learn more:

💡 New in aging research: insights into the metabolic profile of biological aging from the UK Biobank data analyzed by Nightingale Health A recent study published in Nature Communications analyzed the metabolomic profile of aging in 250,341 participants from the UK Biobank,

Are you coming to American Heart Association Scientific Sessions 2024 on November 16-18? Come meet our team at booth 1920 and hear more about Nightingale Health’s affordable metabolomics and scalable remote blood collection.

We are looking for a Data Scientist in Oxford, UK! 🇬🇧🔬 Become a part of our team enabling our blood testing technology that has the potential to change the health of billions of people. Read below, why our Health Insight team member, Principal Scientist Luke Jostins-Dean enjoys

💡 New research highlight combines the data analyzed by Nightingale Health in Estonian Biobank and UK Biobank: unlocking genetic links to metabolite traits in a groundbreaking genome-wide association study! Researchers in a recently published pre-print have conducted a comprehensive

Welcome to our webinar “Prediction of type 2 diabetes complications using metabolomic profiles” on 4 December at 11 a.m. EST! Join us for a session on the potential of metabolomic data from the UK Biobank cohort, focusing specifically on individuals with type 2 diabetes. In this

Today, we had the the opening ceremony of our Singapore laboratory. The laboratory is now ready to serve healthcare and medical research customers in the Southeast Asia region. “With the laboratory set up completed, we can now focus on our sales activities at full speed

Are you attending the UK Biobank Scientific Conference in London on December 10? Nightingale Health has completed the analysis of all 500,000 UK Biobank samples creating the world’s largest blood biomarker database for chronic disease research and prevention. Our Founder &

Our webinar “Metabolomic Profiling: Applications to Maternal Health Research” by Peter Würtz is next week! Remember to sign up and join us on 26 February at 3 p.m. CET. Learn more and sign up: lyyti.fi/reg/maternal-w…

According to the IDF, half a million diabetes-related deaths were preventable in Europe in 2021. Research using Nightingale Health’s metabolomic blood profiling shows that a single blood test can identify individuals at 6-10x higher risk of type 2 diabetes – years before